A detailed history of Horizon Kinetics Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 4,257 shares of LLY stock, worth $3.85 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,257
Previous 4,757 10.51%
Holding current value
$3.85 Million
Previous $3.7 Million 4.16%
% of portfolio
0.07%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $362,435 - $454,520
-500 Reduced 10.51%
4,257 $3.85 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $1,184 - $1,584
2 Added 0.04%
4,757 $3.7 Million
Q4 2023

Feb 15, 2024

SELL
$525.19 - $619.13 $221,630 - $261,272
-422 Reduced 8.15%
4,755 $2.77 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $113,022 - $155,818
-260 Reduced 4.78%
5,177 $2.78 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $1.91 Million - $2.55 Million
5,437 New
5,437 $2.55 Million
Q4 2022

Feb 07, 2023

SELL
$321.55 - $374.67 $160,775 - $187,335
-500 Reduced 6.77%
6,886 $2.52 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $224,850 - $279,040
-1,000 Reduced 11.92%
7,386 $2.04 Million
Q1 2021

May 11, 2021

SELL
$164.32 - $212.72 $454,837 - $588,808
-2,768 Reduced 24.82%
8,386 $1.57 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $130,460 - $172,630
-1,000 Reduced 8.23%
11,154 $1.88 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $146,220 - $169,130
-1,000 Reduced 7.6%
12,154 $1.8 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $454,239 - $530,212
-4,100 Reduced 23.76%
13,154 $1.46 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $1.92 Million - $2.26 Million
17,254 New
17,254 $2.24 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $859B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.